Stocks and Investing Stocks and Investing
Fri, September 15, 2023
Thu, September 14, 2023

Sarah James Maintained (AMED) at Hold with Increased Target to $101 on, Sep 14th, 2023


Published on 2024-10-28 06:25:37 - WOPRAI, Sarah James
  Print publication without navigation


Sarah James of Cantor Fitzgerald, Maintained "Amedisys, Inc." (AMED) at Hold with Increased Target from $100 to $101 on, Sep 14th, 2023.

Sarah has made no other calls on AMED in the last 4 months.



There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, all agree with Sarah's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gary Taylor of "TD Cowen" Maintained at Hold with Increased Target to $101 on, Monday, July 31st, 2023
  • Jonathan Yong of "Credit Suisse" Reiterated at Hold and Held Target at $101 on, Thursday, July 27th, 2023
  • Brian Tanquilut of "Jefferies" Downgraded from Strong Buy to Hold and Increased Target to $101 on, Thursday, July 6th, 2023
  • Bill Sutherland of "Benchmark" Downgraded from Strong Buy to Hold on, Wednesday, June 28th, 2023
  • David Macdonald of "Truist Securities" Maintained at Hold with Increased Target to $101 on, Tuesday, June 27th, 2023
Contributing Sources